PRESSURE BIOSCIENCES - PBIO STOCK NEWS

Welcome to our dedicated page for PRESSURE BIOSCIENCES news (Ticker: PBIO), a resource for investors and traders seeking the latest updates and insights on PRESSURE BIOSCIENCES stock.

Pressure BioSciences, Inc. (PBIO) is a forefront life sciences company that focuses on the development and commercialization of an innovative platform technology known as Pressure Cycling Technology (PCT). This technology employs cycles of hydrostatic pressure, ranging from ambient to ultra-high levels (up to 35,000 psi and beyond), to precisely control biomolecular interactions, offering significant advancements in various scientific fields.

The company's core business revolves around leveraging PCT to enhance the analysis, study, and manipulation of biological samples. This technology has broad applications in areas such as protein characterization, pathogen inactivation, and the preparation of samples for genomic and proteomic studies. By utilizing PCT, researchers and scientists can achieve higher yields, improved quality, and better consistency in their biological analyses.

Recently, PBIO has made notable strides with the introduction of its new consumer products business unit, Uncle Bud’s. In January 2024, the company kicked off with a substantial $252,000 shipment of its Sunburn Soother to one of the world’s largest retailers, showcasing strong market demand and consumer interest. Additionally, VICAR Holdings LLC has committed to purchasing over 10,000 bottles of PBIO's best-in-class Nano-CBD topical spray in 2024, indicating a promising trajectory for their consumer products segment.

PBIO's relocation to a new facility has significantly increased their manufacturing space, enhanced operating efficiencies, and achieved measurable cost savings, setting the stage for unencumbered growth through multi-year expansion plans. The new facility is expected to support the company's long-term strategy and scale operations to meet growing demand.

Uncle Bud's acquisition has already yielded early synergies and measurable performance metrics within the first month, boosting PBIO's market presence and consumer engagement. This positive momentum highlights PBIO's capability to integrate and scale operations effectively.

Furthermore, Pressure BioSciences’ UltraShear platform continues to showcase its potential by enabling the development and launch of health and wellness products with groundbreaking bioavailability, fast onset, and effectiveness. This platform technology is a testament to PBIO's commitment to innovation and enhancing the quality and effectiveness of bio-molecular research and consumer applications.

01/18/2024 11:26 AM

News

Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order

Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) receives an Open Order Agreement for the purchase of over 10,000 bottles of its Nano-CBD Topical Spray in 2024, valued at over $300,000. VICAR Holdings, LLC, a newly formed company with a focus on health and wellness, will be the purchaser. The product will be sold as PrescriptionGrade Nano-CBD and will be the first product available through VICAR's online store. The product is manufactured using PBIO's patented UltraShear™ technology, providing ultrafast speed of action and unprecedented effectiveness. The initial product shipment is expected in the coming weeks, with subsequent shipments to follow quickly thereafter. The contract with VICAR Holdings is seen as a positive indication of the company's momentum in 2024, following the strategic Uncle Bud's announcements.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.26%

Tags

01/16/2024 08:47 AM

News

Pressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January

Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) has announced the acquisition of Uncle Bud’s, a renowned natural health and wellness leader, and the beginning of summer season order filling with one of the globe’s leading retailers. The company shipped a significant $252,000 order for its popular Sunburn Soother, leveraging PBIO’s patented UltraShearTM technology platform for nanoemulsification processing to improve products. The combined company plans to become a leading provider of topicals and other consumer products containing oil-based active ingredients, with a focus on delivering unparalleled speed of action and effective payload bioavailability in preservative-free products with unprecedented long-term stability.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-10.59%

Tags

01/11/2024 08:15 AM

News

Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple Markets

Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) to Acquire Uncle Bud’s, Merging Scientific Capabilities and Natural Health and Wellness Leadership

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-16.88%

Tags

01/04/2024 09:30 AM

News

Pressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies

Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) announced active pursuit of AI and ML partnerships to accelerate product opportunities for their patented BaroFold and Ultra Shear platforms. The company aims to streamline biopharmaceutical R&D and manufacturing using AI/ML tools, potentially revolutionizing the market sectors they are in.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.03%

Tags

12/21/2023 09:40 AM

News

Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform

Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) announced advancements in Ultra Shear Technology with promising applications in various industries such as drug delivery, cosmetics, biotechnology, agriculture, and advanced nanomaterials. The technology aims to produce safer and healthier clean label beverages and emulsions with elongated room temperature stability, potentially revolutionizing the food and beverage industry.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.54%

Tags

12/12/2023 10:40 AM

News

Pressure BioSciences’ UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial Spores

Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) announced the publication of a pivotal scientific study in food safety, featuring the Company's Ultra Shear TechnologyTM platform. The study demonstrates the potential of UltraShear inactivation of foodborne bacterial spores by uniquely combining controlled temperature, pressure, and high fluid shear. The publication signals the future possibility of UltraShear processing of shelf-stable low-acid fluid products to maximize nutritional and sensory qualities while significantly decreasing the potential of bacterial contamination, including spores. The authors validated the compatibility of conventional clean-in-place protocols with the UltraShear equipment. The PR also highlighted other key achievements of the company, including independent confirmation in a peer-reviewed journal that PBIO's UltraShear processing platform delivers oil-based CBD with unprecedented absorption, speed of action, and bioavailability, as well as a 10X increase in Nano CBD topical spray bottles ordered from the Veterans Service Team, indicating a potential multi-million dollar transaction over the next five years.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

12.12%

Tags

12/01/2023 07:30 AM

News

Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador

Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) announces a strategic partnership with the Veterans Service Team (VST) to launch a Nano CBD Topical Spray named 'Valor CBD.' The product is available on the VST website, with initial revenue expected to reach $1.0 million in year 1 and increase to more than $10 million in year 5 of the agreement.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

10.89%

Tags

11/21/2023 09:28 AM

News

Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023

Rhea-AI Summary

Pressure BioSciences, Inc. (PBIO) reported financial results for Q3 2023, with total revenue of $413,000, a 187% increase from Q3 2022. Operating loss decreased by 5%, and cash used from operations reduced by 30%. For the first nine months of 2023, total revenue was $1,665,400, a 48% increase from the same period in 2022. Operating loss increased due to non-cash expenses. PBIO's UltraShear nanoemulsion platform performed exceptionally, with a 10X increase in purchase orders for Nano CBD topical spray and exclusive distribution agreement in India. The company is actively developing new marketing and sales programs for 2024. PBIO is making operational changes to impact revenue and path to profitability in 2024 and beyond.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-8%

Tags

11/20/2023 09:15 AM

News

Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update

Rhea-AI Summary

Pressure BioSciences, Inc. (OTCQB:PBIO) will host a teleconference on November 21, 2023, to discuss its Third Quarter 2023 financial results and provide a business update. The teleconference will cover key developments, including the publication of a scientific study confirming the superior performance of PBIO's patented UltraShear nanoemulsion platform, ongoing collaborations with multi-billion-dollar companies, a 10X increase in orders of UltraShear Nano CBD topical spray, and the planned move to a new manufacturing facility.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

11/08/2023 08:51 AM

News

Peer-Reviewed Scientific Study Independently Confirms Pressure BioSciences’ UltraShear Nanoemulsion Platform Vastly Outperforms Current Technologies, Delivering CBD with Unprecedented Speed, Efficiency, Reliability, and Bioavailability

Rhea-AI Summary

PBIO: UltraShear-Processed CBD Nanoemulsions Achieve 4X Bioavailability, Validates by World-Renowned Researchers

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-1.62%

Tags

FAQ

What is the current stock price of PRESSURE BIOSCIENCES (PBIO)?

The current stock price of PRESSURE BIOSCIENCES (PBIO) is $0.0025 as of December 23, 2024.

What is the market cap of PRESSURE BIOSCIENCES (PBIO)?

The market cap of PRESSURE BIOSCIENCES (PBIO) is approximately 82.2K.

What is Pressure BioSciences, Inc. (PBIO)?

Pressure BioSciences, Inc. (PBIO) is a life sciences company focused on developing and commercializing Pressure Cycling Technology (PCT) to control biomolecular interactions.

What is Pressure Cycling Technology (PCT)?

PCT is a platform technology that uses cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions.

In which areas is PCT technology applied?

PCT technology is applied in protein characterization, pathogen inactivation, and the preparation of samples for genomic and proteomic studies.

What recent achievements has PBIO made?

PBIO recently shipped $252,000 of its Sunburn Soother to a major retailer and secured a purchase order for over 10,000 bottles of Nano-CBD topical spray from VICAR Holdings LLC.

What is Uncle Bud’s?

Uncle Bud’s is PBIO's new consumer products business unit, focusing on health and wellness products such as the Nano-CBD topical spray.

How has PBIO's new facility impacted the company?

The new facility has increased manufacturing space, improved operating efficiencies, and achieved cost savings, supporting PBIO's long-term growth plans.

What is the UltraShear platform?

The UltraShear platform enables the development and launch of health and wellness products with revolutionary bioavailability, fast onset, and effectiveness.

How has Uncle Bud’s performed since its acquisition?

Uncle Bud’s has reported early synergies and measurable performance metrics within the first month, enhancing PBIO's market presence and consumer engagement.

What are some applications of PBIO’s products?

PBIO’s products are used in scientific research for protein analysis, pathogen inactivation, and preparation of biological samples for various studies.

What is the significance of PBIO’s consumer products?

PBIO’s consumer products, such as the Nano-CBD topical spray, offer advanced bioavailability and effectiveness, reflecting the company's innovation in health and wellness.